Abstract: To provide a printing system including an attaching device configured to attach a label on an adherend, and a printer connected to the attaching device and configured to operate in cooperation with the attaching device, in which the printer is configured to send a signal for indicating a state of the printer to the attaching device, and/or receive a signal for performing an operation of the printer from the attaching device, and the attaching device is configured to receive and display the signal for indicating the state of the printer, and/or receive an input of the signal for performing the operation of the printer and send the signal to the printer.

Abstract: To provide a printing system including an attaching device configured to attach a label on an adherend, and a printer connected to the attaching device and configured to operate in cooperation with the attaching device, in which the printer is configured to send a signal for indicating a state of the printer to the attaching device, and/or receive a signal for performing an operation of the printer from the attaching device, and the attaching device is configured to receive and display the signal for indicating the state of the printer, and/or receive an input of the signal for performing the operation of the printer and send the signal to the printer.

Abstract: An embeddable and replenishable controlled drug release device which achieves drug delivery in which the drug release rate can be controlled is provided. The device can be replenished with a drug using a syringe and a needle when implanted in the body. The device has a capsule structure and includes (i) a controlled drug release part for controlled-release of a drug from the device, (ii) a drug storage part for keeping the drug and (iii) a drug introduction part for introducing the drug into the drug storage part. The controlled drug release part has a controlled-release face having a pore, and a hydrogel. The drug storage part is adjacent to the controlled drug release part, and releases the drug kept therein from the pore, and the drug is introduced into the drug storage part through the drug introduction part using a syringe and a needle.

Abstract: A gap is maintained between: an outer surface of a shaft which is inserted in and removed from a hole of a box body and serves as a rotation shaft; and a hole wall, while axial misalignment of the shaft in the hole is inhibited. In a double opening storage device, a lid has two shafts that extend so as to advance and retract along two rotation shafts. Each shaft has a cut portion which is obtained by a part of a circumferential portion of a leading end portion being cut out and disposed in a lower portion at lid closed position. The box body has two holes, formed in a side wall, corresponding to the two shafts of the lid, and has a projection that projects upward from a lower surface of the hole wall of each hole, and that moves the shaft upward when the lid is opened.

Abstract: A capsule device, which can induce vascular bed formation and formation of a space for cell transplantation in subcutaneous tissue in which the device is implanted, is provided. A sustained drug release capsule device, which is to be subcutaneously implanted for subcutaneous sustained release of an angiogenesis-inducing factor as well as formation of a vascular bed as a basis for cell transplantation and a space for cell transplantation in cell therapy, the capsule being made of a material which is not soluble in a biological body and does not adhere to a biological body, and having micropores for sustained release of the angiogenesis-inducing factor.

Abstract: Provided is a novel method of manufacturing a cell-nanoscale thin film composite in which the cell-nanoscale thin film composite can be peeled from a substrate at a controlled timing. The method of manufacturing a cell-nanoscale thin film composite comprises culturing a cell in a cell culture base material in which a nanoscale thin film is provided on an electrode substrate with a self-assembled monolayer interposed therebetween, and reductively desorbing the self-assembled monolayer from the electrode substrate by applying an electric potential to the electrode substrate at a desired timing, so that the cell-nanoscale thin film composite is released.

Abstract: A gap is maintained between: an outer surface of a shaft which is inserted in and removed from a hole of a box body and serves as a rotation shaft; and a hole wall, while axial misalignment of the shaft in the hole is inhibited. In a double opening storage device, a lid has two shafts that extend so as to advance and retract along two rotation shafts. Each shaft has a cut portion which is obtained by a part of a circumferential portion of a leading end portion being cut out and disposed in a lower portion at lid closed position. The box body has two holes, formed in a side wall, corresponding to the two shafts of the lid, and has a projection that projects upward from a lower surface of the hole wall of each hole, and that moves the shaft upward when the lid is opened.

Abstract: A leukocyte measurement device is provided with a spread inspection window at a position separated from an opening part along a spreading direction of a blood-derived sample in a carrier, for making the carrier visible from outside. When the blood-derived sample is dropped from the opening part, leukocytes contained in the blood-derived sample are captured by the carrier in the vicinity of a dropping position, while erythrocytes and/or hemoglobin and the like spread through the carrier from the dropping position into a predetermined direction. Therefore, in the leukocyte measurement device, seeing through the spread inspection window the color of the erythrocytes and/or hemoglobin spread from the dropping position can determine whether it has already been used or not, whereby a simple structure can prevent measurers from erroneously reusing it.

Abstract: A drug delivery system for delivering a drug at a sustained constant rate for a long period, which can be transplanted into an affected part safely and in a simple manner and can deliver a drug to the affected part for a long period. A sustained drug delivery system in which an implant is implanted into a body, wherein the implant is a PEG capsule comprising a box-shaped PEG and a porous PEG sheet.

Abstract: A leukocyte measurement device is provided with a spread inspection window at a position separated from an opening part along a spreading direction of a blood-derived sample in a carrier, for making the carrier visible from outside. When the blood-derived sample is dropped from the opening part, leukocytes contained in the blood-derived sample are captured by the carrier in the vicinity of a dropping position, while erythrocytes and/or hemoglobin and the like spread through the carrier from the dropping position into a predetermined direction. Therefore, in the leukocyte measurement device, seeing through the spread inspection window the color of the erythrocytes and/or hemoglobin spread from the dropping position can determine whether it has already been used or not, whereby a simple structure can prevent measurers from erroneously reusing it.

Abstract: Disclosed is a drug delivery system for delivering a drug at a sustained constant rate for a long period, which can be transplanted into an affected part safely and in a simple manner and can deliver a drug to the affected part for a long period. Specifically disclosed is a sustained drug delivery system in which an implant is implanted into a body, wherein the implant is a PEG capsule comprising a box-shaped PEG and a porous PEG sheet.

Abstract: A drug delivery system for delivering a drug at a sustained constant rate for a long period, which can be transplanted into an affected part safely and in a simple manner and can deliver a drug to the affected part for a long period. A sustained drug delivery system in which an implant is implanted into a body, wherein the implant is a PEG capsule comprising a box-shaped PEG and a porous PEG sheet.

Abstract: Disclosed is a drug delivery system for delivering a drug at a sustained constant rate for a long period, which can be transplanted into an affected part safely and in a simple manner and can deliver a drug to the affected part for a long period. Specifically disclosed is a sustained drug delivery system in which an implant is implanted into a body, wherein the implant is a PEG capsule comprising a box-shaped PEG and a porous PEG sheet.

Abstract: According to one embodiment, a latch mechanism of a disk drive includes a latch member which includes a bearing pivotably mounted on a pivot set up in the disk drive, a main body separated from the bearing, and a bridge portion connecting the bearing and the main body. The bridge portion is less rigid than the main body.

Abstract: A process for producing a lithium-containing composite oxide for a positive electrode active material for use in a lithium secondary battery, the oxide having the formula LipNxMmOzFa (wherein N is at least one element selected from the group consisting of Co, Mn and Ni, M is at least one element selected from the group consisting of Al, alkaline earth metal elements and transition metal elements other than N, 0.9?p?1.2, 0.9?x<1.00, 0<m?0.03, 1.9?z?2.2, x+m=1 and 0?a?0.02), which comprises using as an M element source a solution comprising a complex containing the M element dissolved in an organic solvent.

Abstract: A label affixing apparatus enables an RFID tag to be affixed to a product at a distance from the product. The apparatus comprises: a folding/affixing device which conveys a label, a label holder holds a front surface side of the label, a folding device causes a part of the label including a tag attachment site to project by folding the part from a rear surface side to the front surface side into an angular shape. Either traction is suppressed when the label is affixed to the product. A reader/writer has an antenna in a position facing the part of the label when the part of the label is folded, for reading and writing information from and to the RFID tag. A fold detector detects if the label is folded. The label holding device moves between a label suction position and a label affixing position. Folding is assisted from a rear surface side of the part of the label.

Abstract: According to one embodiment, a disk drive includes a rotatable carriage which supports a head configured to read information from a disk recording medium and to write data to the a disk recording medium, and a latch mechanism configured to latch and hold the carriage in a retracted position when subjected to an external force with the carriage in the retracted position. The latch mechanism includes an engaging portion on the carriage, a first latch pivotably provided on a base in a first mode and includes a latch lug configured to engage the engaging portion, and a second latch pivotably provided on the base in a second mode different from the first mode and includes a latch lug configured to engage the engaging portion.

Abstract: A RFID tag is partially separable from an article to which the tag is applied such that influence on the RFID tag from the article may be reduced thereby. A label is applied to an article, wherein the label is tacked on a backing paper. The label is fixed with a tag-fixed portion fixed with a RFID tag comprising an IC chip and a communication antenna. The tag-fixed portion has a predetermined size and is partitioned from a common label portion. The common label portion is partitioned into a first label portion that is articulated with the tag-fixed portion and a second label portion, from which the tag-fixed portion is separable along a partition line extending across the common label portion from a side of the tag-fixed portion.

Abstract: An ultrasonic cerebral infarction therapeutic apparatus that does not produce side effects of destruction of brain cells, occurrence of intracerebral hemorrhage, destruction of nerve cells, etc. by avoiding formation of a standing wave by interference between an irradiated beam of an ultrasonic wave irradiated to the inside of the cranium and its reflected beam. An ultrasonic probe cap is constructed by arranging a plurality of laminated small transducers each made up of a PVDF film, a PZT ceramic, or the like in a mosaic-like pattern or in other form on the inside of the cap and one or more transducers are selected and activated according to a thrombus position. As a high frequency for actuating a transducer, a continuous sinusoidal wave, a burst wave, or a pulse wave shall be used so that no standing wave may be produced inside the cranium.